Gene · 7317
Papers2,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Respiratory-Predominant Relapsing Polychondritis: The Role of Pet Scan in Making this Challenging Diagnosis. | Eur J Case Rep Intern Med | 2025 | 41064725 | PubTator, text mining | PubMed |
| A Patient with Vexas Syndrome Presenting with Complete Ophthalmoplegia. | Eur J Case Rep Intern Med | 2025 | 41064711 | PubTator, text mining | PubMed |
| Skin Manifestations in VEXAS Syndrome: Specific Clonal Infiltrates versus Non-Specific Reactive Findings. | Case Rep Dermatol | 2025 | 41064309 | PubTator, text mining | PubMed |
| Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review. | Clin Rev Allergy Immunol | 2025 | 41055770 | PubTator, text mining | PubMed |
| Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score. | J Clin Immunol | 2025 | 41026267 | PubTator, text mining | PubMed |
| Cryo-EM reveals evolutionarily conserved and distinct structural features of plant CG maintenance methyltransferase MET1. | Nat Commun | 2025 | 41006297 | PubTator, text mining | PubMed |
| Characteristics of Myelodysplastic Syndrome with Coagulation Abnormalities and Tailored Diagnosis and Treatment. | J Pers Med | 2025 | 41003132 | PubTator, text mining | PubMed |
| Characterizing VEXAS syndrome in women: Findings from an international multicenter study. | J Intern Med | 2025 | 40985189 | PubTator, text mining | PubMed |
| Thiosemicarbazones down-regulate N-Myc expression in neuroblastoma cells via transcriptional and post-translational mechanisms. | Pharmacol Res | 2025 | 40976460 | PubTator, text mining | PubMed |
| Post-translational modification of H2B C-terminal helix regulates nucleosome interactions and chromatin signaling. | Nucleic Acids Res | 2025 | 40966523 | PubTator, text mining | PubMed |
| VEXAS syndrome: more than just vacuoles. | Hematol Transfus Cell Ther | 2025 | 40961863 | PubTator, text mining | PubMed |
| [VEXAS syndrome]. | Z Rheumatol | 2025 | 40960635 | PubTator, text mining | PubMed |
| STK4 inhibits the E3 activity of HOIP by phosphorylating its allosteric ubiquitin-binding site. | Cell Discov | 2025 | 40957900 | PubTator, text mining | PubMed |
| VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms. | Lancet Rheumatol | 2025 | 40915300 | PubTator, text mining | PubMed |
| From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome. | Rheumatol Int | 2025 | 40905972 | PubTator, text mining | PubMed |
| Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1. | Nat Commun | 2025 | 40897715 | PubTator, text mining | PubMed |
| Vacuolated Marrow Cytopenias from Copper Deficiency to UBA1-Mutant VEXAS: Molecular Landscape, Systematic Review, and Cost-Efficient Diagnostic Algorithm. | Int J Mol Sci | 2025 | 40869363 | PubTator, text mining | PubMed |
| VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies. | Int J Mol Sci | 2025 | 40869252 | PubTator, text mining | PubMed |
| SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms. | Leukemia | 2025 | 40858805 | PubTator, text mining | PubMed |
| SLFN11, far from being limited to responding to cancer DNA damage. | Clin Exp Med | 2025 | 40856812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7317/papers?page=8